{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:40:08Z","timestamp":1791862808814,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite management. This group of patients has been collectively termed the progressive fibrotic phenotype (PFP). Their early recognition may facilitate access to antifibrotic therapies to prevent or slow progression. Macrophages\/monocytes within the lung orchestrate the progression and maintenance of fibrosis. A novel role for monocyte-derived macrophages during tissue damage and wound healing is the expression of collagens. We examined Collagen 1a1 expression in airway macrophages from ILD patients at diagnosis. COL1A1 mRNA levels from BAL cells were elevated in IPF and Non-IPF patients. The presence of a UIP pattern and a subsequent progressive phenotype were significantly associated with the higher BAL COL1A1 levels. In Non-IPF patients, higher COL1A1 levels were associated with a more than twofold increase in mortality. The intracellular localisation of COL1A1 in airway macrophages was demonstrated by confocal microscopy in CD45 and CD163 co-staining assays. Additionally, airway macrophages co-expressed COL1A1 with the profibrotic SPP1 gene product osteopontin. The levels of SPP1 mRNA and OPN in the BAL were significantly higher in IPF and Non-IPF patients relative to healthy. Our results suggest that profibrotic airway macrophages are increased in the BAL of patients with IPF and other ILDs and co-express COL1A1 and OPN. Importantly, COL1A1 expression by pro-fibrotic airway macrophages could be a marker of disease progression and poor survival in ILDs.<\/jats:p>","DOI":"10.3389\/fimmu.2021.645548","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:38:04Z","timestamp":1637134684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality"],"prefix":"10.3389","volume":"12","author":[{"given":"Eliza","family":"Tsitoura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Trachalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Vasarmidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semeli","family":"Mastrodemou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Margaritopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kokosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Fanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Galaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Aidinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Renzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Tzanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina M.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1183\/09059180.00009113","article-title":"Interstitial Lung Disease","volume":"23","author":"Antoniou","year":"2014","journal-title":"Eur Respir Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00692-2018","article-title":"What's in a Name? That Which We Call IPF, by Any Other Name Would Act the Same","volume":"51","author":"Wells","year":"2018","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing Interstitial Lung Diseases: Knowns and Unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev an Off J Eur Respir Soc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00085-2020","article-title":"The Natural History of Progressive Fibrosing Interstitial Lung Diseases","volume":"55","author":"Brown","year":"2020","journal-title":"Eur Respir J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of Nintedanib in Treatment of Progressive Fibrosing Interstitial Lung Diseases","volume":"1900161","author":"Wollin","year":"2019","journal-title":"Eur Respir J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.10.050","article-title":"Endotype\u2013Phenotyping may Predict a Treatment Response in Progressive Fibrosing Interstitial Lung Disease","volume":"50","author":"Hoffmann-Vold","year":"2019","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting Outcomes in Rheumatoid Arthritis Related Interstitial Lung Disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chest.2018.08.1076","article-title":"Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory","volume":"155","author":"Salisbury","year":"2019","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"170117","DOI":"10.1183\/16000617.0117-2017","article-title":"Personalised Medicine in Interstitial Lung Diseases","volume":"27","author":"Kokosi","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and Immunity in IPF Pathogenesis and Treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30172-9","article-title":"Long-Term Treatment With Recombinant Human Pentraxin 2 Protein in Patients With Idiopathic Pulmonary Fibrosis: An Open-Label Extension Study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3164\/jcbn.17-111","article-title":"Pirfenidone Suppresses Polarization to M2 Phenotype Macrophages and the Fibrogenic Activity of Rat Lung Fibroblasts","volume":"63","author":"Toda","year":"2018","journal-title":"J Clin Biochem Nutr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-Derived Alveolar Macrophages Drive Lung Fibrosis and Persist in the Lung Over the Life Span","volume":"214","author":"Misharin","year":"2017","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-Derived Alveolar Macrophages Drive Lung Fibrosis and Persist in the Lung Over the Life Span","volume":"214","author":"Misharin","year":"2017","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: Friend or Foe in Idiopathic Pulmonary Fibrosis","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: Emerging Effector Cells in Chronic Inflammation","volume":"11","author":"Reilkoff","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space After Fibrotic Injury","volume":"166","author":"Moore","year":"2005","journal-title":"Am J Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-Cell Transcriptomic Analysis of Human Lung Provides Insights Into the Pathobiology of Pulmonary Fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5707","article-title":"Production of Type VI Collagen by Human Macrophages: A New Dimension in Macrophage Functional Heterogeneity","volume":"180","author":"Schnoor","year":"2008","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of Markers That Distinguish Monocyte-Derived Fibrocytes From Monocytes, Macrophages, and Fibroblasts","volume":"4","author":"Pilling","year":"2009","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41467-019-14263-2","article-title":"Macrophages Directly Contribute Collagen to Scar Formation During Zebrafish Heart Regeneration and Mouse Heart Repair","volume":"11","author":"Simoes","year":"2020","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125366","article-title":"Fra-2-Expressing Macrophages Promote Lung Fibrosis in Mice","volume":"129","author":"Ucero","year":"2019","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12931-019-1196-6","article-title":"Accumulation of Damaged Mitochondria in Alveolar Macrophages With Reduced OXPHOS Related Gene Expression in IPF","volume":"20","author":"Tsitoura","year":"2019","journal-title":"Respir Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12740","article-title":"MiR-185\/AKT and miR-29a\/Collagen 1a Pathways Are Activated in IPF BAL Cells","volume":"7","author":"Tsitoura","year":"2016","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-Expressing Macrophages in Idiopathic Pulmonary Fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct From Kupffer Cells in the Fatty Liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1371\/journal.pmed.0020251","article-title":"Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis","volume":"2","author":"Pardo","year":"2005","journal-title":"PloS Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0862OC","article-title":"Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis From Other Idiopathic Interstitial Pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30185-1","article-title":"Prognostic and Predictive Biomarkers for Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone: Post-Hoc Assessment of the CAPACITY and ASCEND Trials","volume":"6","author":"Neighbors","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/hep.31582","article-title":"Osteopontin Takes Center Stage in Chronic Liver Disease","volume":"73","author":"Song","year":"2020","journal-title":"Hepatol (Baltimore Md)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155568","article-title":"Osteopontin: The Molecular Bridge Between Fat and Cardiac-Renal Disorders","volume":"21","author":"Vianello","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1138LE","article-title":"Bronchoalveolar Lavage Is Safe and Well Tolerated in Individuals With Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study","volume":"3","author":"Molyneaux","year":"2020","journal-title":"Am J Respir And Crit Care Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e20200096","DOI":"10.36416\/1806-3756\/e20200096","article-title":"Importance of Chest HRCT in the Diagnostic Evaluation of Fibrosing Interstitial Lung Diseases","volume":"47","author":"Torres","year":"2021","journal-title":"Jornal Brasileiro Pneumologia Publicacao Oficial da Sociedade Bras Pneumologia e Tisilogia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic Criteria for Idiopathic Pulmonary Fibrosis: A Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic Criteria for Idiopathic Pulmonary Fibrosis: A Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00269","article-title":"Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice","volume":"5","author":"Barbayianni","year":"2018","journal-title":"Front Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2551OC","article-title":"BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis","volume":"199","author":"Prasse","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00235.2017","article-title":"Metabolic Characterization and RNA Profiling Reveal Glycolytic Dependence of Profibrotic Phenotype of Alveolar Macrophages in Lung Fibrosis","volume":"313","author":"Xie","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"New Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"00172","DOI":"10.1183\/23120541.00172-2019","article-title":"Efficacy and Safety of Nintedanib in a Greek Multicentre Idiopathic Pulmonary Fibrosis Registry: A Retrospective, Observational, Cohort Study","volume":"6","author":"Antoniou","year":"2020","journal-title":"ERJ Open Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"New Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Diseases-Subgroup Analyses by Interstitial Lung Disease Diagnosis in the INBUILD Trial: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis\u2013Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"New Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12890-018-0736-z","article-title":"Pirfenidone Improves Survival in IPF: Results From a Real-Life Study","volume":"18","author":"Margaritopoulos","year":"2018","journal-title":"BMC Pulm Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease: A Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12890-019-0943-2","article-title":"Demographic and Clinical Predictors of Progression and Mortality in Connective Tissue Disease-Associated Interstitial Lung Disease: A Retrospective Cohort Study","volume":"19","author":"Chan","year":"2019","journal-title":"BMC Pulm Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01565-2015","article-title":"Characterisation of Patients With Interstitial Pneumonia With Autoimmune Features","volume":"47","author":"Oldham","year":"2016","journal-title":"Eur Respir J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.rmed.2017.07.007","article-title":"Unclassifiable-Interstitial Lung Disease: Outcome Prediction Using CT and Functional Indices","volume":"130","author":"Jacob","year":"2017","journal-title":"Respir Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B Promoter Variant and Rheumatoid Arthritis With Interstitial Lung Disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-Producing Lung Cell Atlas Identifies Multiple Subsets With Distinct Localization and Relevance to Fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.09.03","article-title":"Elevation of Pulmonary CD163(+) and CD204(+) Macrophages Is Associated With the Clinical Course of Idiopathic Pulmonary Fibrosis Patients","volume":"11","author":"Nouno","year":"2019","journal-title":"J Thorac Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"100140","DOI":"10.1016\/j.xcrm.2020.100140","article-title":"Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis","volume":"1","author":"Gao","year":"2020","journal-title":"Cell Rep Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz221","article-title":"Specific Macrophage Populations Promote Both Cardiac Scar Deposition and Subsequent Resolution in Adult Zebrafish","volume":"116","author":"Bevan","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151193","article-title":"Tumor Macrophages Are Pivotal Constructors of Tumor Collagenous Matrix","volume":"213","author":"Afik","year":"2016","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.645548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:38:08Z","timestamp":1637134688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.645548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2021.645548"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.645548","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"article-number":"645548"}}